Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 241721, 7 pages
http://dx.doi.org/10.1155/2013/241721
Research Article

The Escherichia coli-Derived Thymosin β4 Concatemer Promotes Cell Proliferation and Healing Wound in Mice

Plant Biotechnology Research Center, School of Agriculture and Biology, Fudan-SJTU-Nottingham, Plant Biotechnology R and D Center, Shanghai Jiao Tong University, Shanghai 200240, China

Received 21 January 2013; Revised 5 April 2013; Accepted 17 April 2013

Academic Editor: Youngjun Choi

Copyright © 2013 Xiaolei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. K. Low, S. K. Hu, and A. L. Goldstein, “Complete amino acid sequence of bovine thymosin β4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 2, pp. 1162–1166, 1981. View at Google Scholar · View at Scopus
  2. B. Can, F. Karagoz, L. Yildiz, M. Kefeli, G. Gonullu, and B. Kandemir, “Thymosin β4 is a novel potential prognostic marker in gastrointestinal stromal tumors,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 120, no. 9, pp. 689–698, 2012. View at Google Scholar
  3. J. Caers, E. Otjacques, D. Hose, B. Klein, and K. Vanderkerken, “Thymosin β4 in multiple myeloma: friend or foe,” Annals of the New York Academy of Sciences, vol. 1194, pp. 125–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Chen, M. Li, H. Yang, H. Chai, W. Fisher, and Q. Yao, “Roles of thymosins in cancers and other organ systems,” World Journal of Surgery, vol. 29, no. 3, pp. 264–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Huff, C. S. G. Müller, A. M. Otto, R. Netzker, and E. Hannappel, “β-thymosins, small acidic peptides with multiple functions,” International Journal of Biochemistry and Cell Biology, vol. 33, no. 3, pp. 205–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Safer, M. Elzinga, and V. T. Nachmias, “Thymosin β4 and Fx, an actin-sequestering peptide, are indistinguishable,” Journal of Biological Chemistry, vol. 266, no. 7, pp. 4029–4032, 1991. View at Google Scholar · View at Scopus
  7. M. Van Troys, D. Dewitte, M. Goethals, M. F. Carlier, J. Vandekerckhove, and C. Ampe, “The actin binding site of thymosin β4 mapped by mutational analysis,” EMBO Journal, vol. 15, no. 2, pp. 201–210, 1996. View at Google Scholar · View at Scopus
  8. K. Matsuo, Y. Akasaki, K. Adachi et al., “Promoting effects of thymosin β4 on granulation tissue and new bone formation after tooth extraction in rats,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, vol. 114, no. 1, pp. 17–26, 2012. View at Google Scholar
  9. G. Sosne, P. Qiu, M. Kurpakus-Wheater, and H. Matthew, “Thymosin β4 and corneal wound healing: visions of the future,” Annals of the New York Academy of Sciences, vol. 1194, pp. 190–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. Cha, M. J. Jeong, and H. K. Kleinman, “Role of thymosin β4 in tumor metastasis and angiogenesis,” Journal of the National Cancer Institute, vol. 95, no. 22, pp. 1674–1680, 2003. View at Google Scholar · View at Scopus
  11. N. Smart, A. Rossdeutsch, and P. R. Riley, “Thymosin β4 and angiogenesis: modes of action and therapeutic potential,” Angiogenesis, vol. 10, no. 4, pp. 229–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Marx, “Thymosins: clinical promise after a decades-long search,” Science, vol. 316, no. 5825, pp. 682–683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Wei, S. Kumar, I. K. Kim, and S. Gupta, “Thymosin Beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes,” Public Library of Science One, vol. 7, no. 8, Article ID e42586, 2012. View at Google Scholar
  14. G. Sosne, C. C. Chan, K. Thai et al., “Thymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo,” Experimental Eye Research, vol. 72, no. 5, pp. 605–608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Sosne, E. A. Szliter, R. Barrett, K. A. Kernacki, H. Kleinman, and L. D. Hazlett, “Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury,” Experimental Eye Research, vol. 74, no. 2, pp. 293–299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. L. K. Low, C. Y. Lin, T. L. Pan, A. J. Chiou, and A. Tsugita, “Structure and immunological properties of thymosin β9Met, a new analog of thymosin β4 isolated from porcine thymus,” International Journal of Peptide and Protein Research, vol. 36, no. 6, pp. 481–488, 1990. View at Google Scholar · View at Scopus
  17. C. S. Cierniewski, I. Papiewska-Pajak, M. Malinowski et al., “Thymosin β4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80,” Annals of the New York Academy of Sciences, vol. 1194, pp. 60–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. W. S. Wang, P. M. Chen, H. L. Hsiao, H. S. Wang, W. Y. Liang, and Y. Su, “Overexpression of the thymosin β-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma,” Oncogene, vol. 23, no. 39, pp. 6666–6671, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Y. Yoon, H. R. Lee, Y. Park et al., “Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer,” Oncology Reports, vol. 25, no. 1, pp. 23–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Goldstein, “Thymosin β4: a new molecular target for antitumor strategies,” Journal of the National Cancer Institute, vol. 95, no. 22, pp. 1646–1647, 2003. View at Google Scholar · View at Scopus
  21. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Google Scholar · View at Scopus
  22. K. M. Malinda, G. S. Sidhu, H. Mani et al., “Thymosin β4 accelerates wound healing,” Journal of Investigative Dermatology, vol. 113, no. 3, pp. 364–368, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Li, L. Zheng, F. Peng et al., “Recombinant thymosin beta 4 can promote full-thickness cutaneous wound healing,” Protein Expression and Purification, vol. 56, no. 2, pp. 229–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Wallenstein, C. L. Zucker, and J. L. Fleiss, “Some statistical methods useful in circulation research,” Circulation Research, vol. 47, no. 1, pp. 1–9, 1980. View at Google Scholar · View at Scopus
  25. S. S. Wang, B. S. Wang, J. K. Chang, T. K. Low, and A. L. Goldstein, “Synthesis of thymosin β4,” International Journal of Peptide and Protein Research, vol. 18, no. 4, pp. 413–415, 1981. View at Google Scholar
  26. K. E. Jones, N. G. Patel, M. A. Levy et al., “Global trends in emerging infectious diseases,” Nature, vol. 451, no. 7181, pp. 990–993, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Low and A. Goldstein, “Thymosins: structure, function and therapeutic applications,” Thymus, vol. 6, no. 1-2, pp. 27–42, 1984. View at Google Scholar
  28. L. Avesani, L. Bortesi, L. Santi, A. Falorni, and M. Pezzotti, “Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?” Expert Review of Vaccines, vol. 9, no. 8, pp. 957–969, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. K. C. Ma, P. M. W. Drake, and P. Christou, “The production of recombinant pharmaceutical proteins in plants,” Nature Reviews Genetics, vol. 4, no. 10, pp. 794–805, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. C. L. Nykiforuk, Y. Shen, E. W. Murray et al., “Expression and recovery of biologically active recombinant Apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds,” Plant Biotechnology Journal, vol. 9, no. 2, pp. 250–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. U. Gerngross, “Advances in the production of human therapeutic proteins in yeasts and filamentous fungi,” Nature Biotechnology, vol. 22, no. 11, pp. 1409–1414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. T. N. Athmaram, S. Saraswat, S. R. Santhosh et al., “Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice,” Virology Journal, vol. 8, p. 524, 2011. View at Google Scholar